SEC Form 4Coverage since Jun 1, 2026
$STOK insider trading
Over the last 12 months, Stoke Therapeutics insiders reported no purchases and 4 sales totaling $543K across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $543K 4 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $STOK · 12Mvia TradingView
Top insiders · 12m
Ticho BarryCHIEF MEDICAL OFFICER3× · $499K
Allan JonathanGENERAL COUNSEL & CORP SEC1× · $44K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Ticho BarryCHIEF MEDICAL OFFICER · O | ▼ Sale | 7,176 | $29.04 | $208K | -26% | plan · 2 tranches |
| Jul 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER · O | ▼ Sale | 7,228 | $32.66 | $236K | -20.8% | plan · 2 tranches |
| Jun 16, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC · O | ▼ Sale | 1,457 | $29.95 | $44K | -7.5% | plan |
| Jun 1, 2026 | Ticho BarryCHIEF MEDICAL OFFICER · O | ▼ Sale | 1,795 | $30.58 | $55K | -4.9% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $STOK feed.